articleInternational Journal of CancerApr 25, 2019HYBRID OA

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients

Semmelweis University · Institute of Molecular Life Sciences · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Systemic therapy of breast cancer can include chemotherapy, hormonal therapy and targeted therapy. Prognostic biomarkers are able to predict survival and predictive biomarkers are able to predict therapy response. In this report, we describe the initial release of the first available online tool able to identify gene expression-based predictive biomarkers using transcriptomic data of a large set of breast cancer patients. Published gene expression data of 36 publicly available datasets were integrated with treatment data into a unified database. Response to therapy was determined using either author-reported pathological complete response data (n = 1,775) or relapse-free survival status at 5 years (n = 1,329).…

Citation impact

453
total citations
FWCI
14.39
Percentile
100%
References
39
Citations per year

Authors

2

Topics & keywords

Keywords
  • Breast cancer
  • Oncology
  • Medicine
  • Hormonal therapy
  • Internal medicine
  • Biomarker
  • Chemotherapy
  • Trastuzumab
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.